image
Healthcare - Biotechnology - NASDAQ - US
$ 9.86
-3.8 %
$ 83.8 M
Market Cap
-0.46
P/E
CASH FLOW STATEMENT
-17.6 M OPERATING CASH FLOW
56.33%
-26 K INVESTING CASH FLOW
-0.05%
16.2 M FINANCING CASH FLOW
5760.87%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Surrozen, Inc.
image
00(10m)(10m)(20m)(20m)(30m)(30m)(40m)(40m)(50m)(50m)(60m)(60m)202020202021202120222022202320232024202420252025
Net Income -63.6 M
Depreciation & Amortization 1.44 M
Capital Expenditures -26 K
Stock-Based Compensation 4.11 M
Change in Working Capital 0
Others 40.4 M
Free Cash Flow -17.7 M

Cash Flow

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019
OPERATING CASH FLOW
Net Income (63.6) (43.0) (36.0) (54.6) (32.7) (24.4)
Depreciation & Amortization 1.4 1.9 2.0 2.1 1.9 2.3
Deferred Income Tax 0 0 0 0.4 1 K 0
Stock Based Compensation 4.1 4.4 4.5 2.3 0.6 0.8
Other Operating Activities 40.4 0.3 (6.2) 1.2 1.0 1.3
Change in Working Capital 0 (3.9) (8.4) (0.2) 52 K (1.1)
Cash From Operations (17.6) (40.4) (44.1) (48.8) (29.1) (21.1)
INVESTING CASH FLOW
Capital Expenditures 26 K (0.4) (0.7) (1.3) (0.9) (1.6)
Other Items 0 52.1 39.0 (76.4) (14.2) 0
Cash From Investing Activities 26 K 51.7 38.3 (77.7) (15.1) (1.6)
FINANCING CASH FLOW
Common Stock Repurchased 0 59 K (2.6) 1 K 1 K 13 K
Total Debt Repaid 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0
Other Financing Activities 0.1 0.3 42 K 0.4 50.1 28.9
Cash From Financing Activities 16.2 0.3 (2.6) 124.6 50.1 28.9
CHANGE IN CASH
Net Change In Cash (1.5) 11.6 (8.4) (1.9) 5.9 29.5
FREE CASH FLOW
Free Cash Flow (17.7) (40.8) (44.9) (50.1) (30.0) (22.6)